Table 1.
Summary of categorical demographic and baseline characteristics by treatment group, all enrolled participants.
| PfSPZ-CVac (N = 31) | Control (N = 31) | ||
|---|---|---|---|
| Variable | Characteristic | n (%) | n (%) |
| Sex | Male | 20 (65) | 26 (84) |
| Female | 11 (35) | 5 (16) | |
| Baseline malaria infection by thick smear microscopy | Yes | 0 (0) | 0 (0) |
| No | 31 (100) | 31 (100) | |
| Age (years) | |||
| Mean Age (SD) | 31·5 (8·9) | 29·3 (8·0) | |
| Age Range | 18-44 | 18-42 | |